UnknownNot Applicable

HYPNAYA Feasibility Study

Netherlands30 participantsStarted 2023-07-17

Plain-language summary

Adolescents and young adults (AYAs) with a cancer diagnosis experience high levels of stress during and after treatment. Hypnotherapy as supportive treatment throughout regular cancer care may reduce symptoms of distress, and improve sleep and health-related quality of life in AYAs with cancer. The objective of this pilot study is to demonstrate feasibility of hypnotherapy as supportive treatment.

Who can participate

Age range18 Years – 39 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria * Consecutive AYA patients undergoing systemic treatment or follow-up up to 6 months after finishing medical treatment at the Amsterdam University Medical Centers in Amsterdam, will be invited to participate. * The Dutch definition of AYA is patients aged 18-39 years at cancer diagnosis. * All patients need to be fluent in Dutch * Able to understand the informed consent form * Willing to provide written informed consent. Exclusion criteria * Patients that are actively treated by a psychiatrist will not be able to participate in this study to prevent interference with ongoing psychiatric treatment. * Patients that are mentally incompetent (based on the opinion of the treating physician) will be excluded. * Patients that previously received hypnotherapy will also be excluded.

What they're measuring

Feasibility of hypnotherapy as supportive treatment for AYA patients

Timeframe: 8 weeks

Trial details

NCT IDNCT06021093

SponsorAcademisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2024-08-01

View on ClinicalTrials.gov More AYA Cancer Patients trials